|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C12N2310/20 | (2017.05) | ||
| A61K 31/7088 | (2006.01) | ||
| A61K 48/005 | (2013.01) | ||
| C12N 15/115 | (2010.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C12N 15/64 | (2006.01) | ||
| A61K 48/0008 | (2013.01) | ||
| A61K 31/7105 | (2006.01) | ||
| A61K 48/0041 | (2013.01) | ||
| C12N 15/88 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| C12N 15/85 | (2006.01) | ||
| A61K 39/39 | (2013.01) | ||
| C12N 15/11 | (2006.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61K 39/001112 | (2018.08) | ||
| A61K 39/0011 | (2013.01) | ||
| A61K 31/713 | (2013.01) | ||
| C12N 15/1137 | (2013.01) | ||
| C12N2310/14 | (2013.01) | ||
| C12Y 304/21021 | (2013.01) | ||
| C12N2310/532 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/1272 | (2013.01) | ||
| A61K 9/1271 | (2013.01) | ||
| C07K2319/50 | (2013.01) |
| (11) | Number of the document | 3920976 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20834039.8 |
| Date of filing the European patent application | 2020-12-04 | |
| (97) | Date of publication of the European application | 2021-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/063494 |
| Date | 2020-12-04 |
| (87) | Number | WO 2021/113777 |
| Date | 2021-06-10 |
| (30) | Number | Date | Country code |
| 201962943779 P | 2019-12-04 | US | |
| 201962943797 P | 2019-12-04 | US | |
| 202062972194 P | 2020-02-10 | US | |
| 202063022248 P | 2020-05-08 | US | |
| 202063087582 P | 2020-10-05 | US |
| (72) |
GOODMAN, Brian , US
WESSELHOEFT, Alexander , US
HORHOTA, Allen T. , US
YANG, Junghoon , US
OTT, Kristen , US
|
| (73) |
Orna Therapeutics, Inc. ,
620 Memorial Drive, 2nd Floor, Cambridge, MA 02139,
US
|
| (54) | CIRCULAR RNA COMPOSITIONS AND METHODS |
| CIRCULAR RNA COMPOSITIONS AND METHODS |